Eukaryotic cells employ at least three nuclear, DNA-dependent RNA polymerase systems for the synthesis of cellular RNA. RNA polymerases I, II, and III primarily produce rRNA, mRNA, and tRNA, respectively. In a rapidly growing cell, most RNA synthesis is devoted to production of the translation machinery, with rRNA synthesis by RNA polymerase I representing more than half of total cellular transcription. The fundamental connection between ribosome biogenesis and cell growth is clear; furthermore, recent studies have identified transcription by RNA polymerase I as a key target for anticancer chemotherapy. Thus, efficient methods for characterizing transcription of the ribosomal DNA and its regulation are needed. In order to describe enzymatic features of an enzyme, in vitro assays are critical. Here we describe a method for purifying RNA polymerase I. This approach yields enzyme of sufficiently high quantity and activity for an array of experiments directed at describing the enzymatic properties of RNA polymerase I in detail.
RNA polymerase I Transcription rRNA Ribosome Protein purification
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
The authors thank the UAB Fermentation Facility for continual support in cell growth and harvesting. This work is supported by the National Institutes of Health grant #GM84946.
Schneider DA (2012) RNA polymerase I activity is regulated at multiple steps in the transcription cycle: recent insights into factors that influence transcription elongation. Gene 493:176–184CrossRefPubMedCentralPubMedGoogle Scholar
Viktorovskaya OV, Engel KL, French SL et al (2013) Divergent contributions of conserved active site residues to transcription by eukaryotic RNA polymerases I and II. Cell Rep 4:974–984CrossRefPubMedCentralPubMedGoogle Scholar
Roeder RG, Rutter WJ (1969) Multiple forms of DNA-dependent RNA polymerase in eukaryotic organisms. Nature 224:234–237CrossRefPubMedGoogle Scholar
Bywater MJ, Poortinga G, Sanij E et al (2012) Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 22:51–65CrossRefPubMedCentralPubMedGoogle Scholar
Drygin D, Lin A, Bliesath J et al (2011) Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res 71:1418–1430CrossRefPubMedGoogle Scholar
Pianese G (1896) Beitrag zur Histologie und Aetiologie der Carcinoma: Histologische und experimentelle Untersuchungen. Beitr Pathol Anat Allgem Pathol 142:1–193Google Scholar
Hannan RD, Drygin D, Pearson RB (2013) Targeting RNA polymerase I transcription and the nucleolus for cancer therapy. Expert Opin Ther Targets 17:873–878CrossRefPubMedGoogle Scholar
Grummt I (2003) Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev 17:1691–1702CrossRefPubMedGoogle Scholar
Nomura M, Nogi Y, Oakes M (2004) Transcription of rDNA in the yeast Saccharomyces cerevisiae. In: Olson MOJ (ed) The nucleolus. Kluwer Academic, London, pp 128–153Google Scholar
Keener JJC, Dodd JA, Nomura M (1998) Reconstitution of yeast RNA polymerase I transcription in vitro from purified components. TATA-binding protein is not required for basal transcription. J Biol Chem 273:33795–33802CrossRefPubMedGoogle Scholar
Schneider DA, Michel A, Sikes ML et al (2007) Transcription elongation by RNA polymerase I is linked to efficient rRNA processing and ribosome assembly. Mol Cell 26:217–229CrossRefPubMedCentralPubMedGoogle Scholar
Schneider DA (2012) Quantitative analysis of transcription elongation by RNA polymerase I in vitro. Methods Mol Biol 809:579–591CrossRefPubMedGoogle Scholar
Zhang Y, Smith AD, Renfrow MB et al (2010) The RNA polymerase-associated factor 1 complex (Paf1C) directly increases the elongation rate of RNA polymerase I and is required for efficient regulation of rRNA synthesis. J Biol Chem 285:14152–14159CrossRefPubMedCentralPubMedGoogle Scholar